文献库，生知库 | 链接生命科学的每一步

Woroniecka, Renata; Rymkiewicz, Grzegorz; Bystydzienski, Zbigniew; Pienkowska-Grela, Barbara; Rygier, Jolanta; Malawska, Natalia; Wojtkowska, Katarzyna; Goral, Nikolina; Blachnio, Katarzyna; Chmielewski, Marcin; Bartnik-Glaska, Magdalena; Grygalewicz, Beata

细胞生物学

发表日期：2023

文献求助收藏

PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients

PROM1、CXCL8、RUNX1、NAV1 和 TP73 基因作为独立标志物，可预测两组高级别浆液性卵巢癌患者的预后或治疗反应。

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0271539

Dansonka-Mieszkowska, Agnieszka; Szafron, Laura Aleksandra; Kulesza, Magdalena; Stachurska, Anna; Leszczynski, Pawel; Tomczyk-Szatkowska, Agnieszka; Sobiczewski, Piotr; Parada, Joanna; Kulinczak, Mariusz; Moes-Sosnowska, Joanna; Pienkowska-Grela, Barbara; Kupryjanczyk, Jolanta; Chechlinska, Magdalena; Szafron, Lukasz Michal

Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.

Burkitt淋巴瘤中的隐匿性MYC插入：新数据和文献综述

期刊:PLoS One

影响因子:2.6

doi:10.1371/journal.pone.0263980

Woroniecka Renata, Rymkiewicz Grzegorz, Szafron Lukasz M, Blachnio Katarzyna, Szafron Laura A, Bystydzienski Zbigniew, Pienkowska-Grela Barbara, Borkowska Klaudia, Rygier Jolanta, Kotyl Aleksandra, Malawska Natalia, Wojtkowska Katarzyna, Parada Joanna, Borysiuk Anita, Murcia Pienkowski Victor, Rydzanicz Malgorzata, Grygalewicz Beata

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer

EMSY基因表达和多态性在卵巢癌中的临床意义

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.24878

Dansonka-Mieszkowska, Agnieszka; Szafron, Lukasz M; Moes-Sosnowska, Joanna; Kulinczak, Mariusz; Balcerak, Anna; Konopka, Bozena; Kulesza, Magdalena; Budzilowska, Agnieszka; Lukasik, Martyna; Piekarska, Urszula; Rzepecka, Iwona K; Parada, Joanna; Zub, Renata; Pienkowska-Grela, Barbara; Madry, Radoslaw; Siwicki, Jan K; Kupryjanczyk, Jolanta

The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS

11q 获得/缺失异常在伴有 11q 异常的 MYC 阴性 Burkitt 样淋巴瘤、MYC 阳性 Burkitt 淋巴瘤以及 MYC 阳性高级别 B 细胞淋巴瘤（未另行分类）中反复出现。

期刊:American Journal of Clinical Pathology

影响因子:1.9

doi:10.1093/ajcp/aqx139

Grygalewicz, Beata; Woroniecka, Renata; Rymkiewicz, Grzegorz; Rygier, Jolanta; Borkowska, Klaudia; Kotyl, Aleksandra; Blachnio, Katarzyna; Bystydzienski, Zbigniew; Nowakowska, Beata; Pienkowska-Grela, Barbara

A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.

在青年成人B细胞急性淋巴细胞白血病中发现一种与CDKN2A/B缺失相关的新型IGH@基因重排

期刊:Oncology Letters

影响因子:2.2

doi:10.3892/ol.2016.4169

Othman Moneeb A K, Grygalewicz Beata, Pienkowska-Grela Barbara, Rygier Jolanta, Ejduk Anna, Rincic Martina, Melo Joana B, Carreira Isabel M, Meyer Britta, Liehr Thomas

细胞生物学

发表日期：2016

文献求助收藏

Novel Cryptic Rearrangements in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Involving the MLL Gene.

涉及 MLL 基因的成人 B 细胞前体急性淋巴细胞白血病的新型隐匿性重排

期刊:Journal of Histochemistry & Cytochemistry

影响因子:1.5

doi:10.1369/0022155415576201

Othman Moneeb A K, Grygalewicz Beata, Pienkowska-Grela Barbara, Rincic Martina, Rittscher Katharina, Melo Joana B, Carreira Isabel M, Meyer Britta, Marzena Watek, Liehr Thomas

细胞生物学

发表日期：2015

文献求助收藏

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients

假定的癌基因CRNDE是卵巢癌患者的不良预后因素。

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.6016

Szafron, Lukasz Michal; Balcerak, Anna; Grzybowska, Ewa Anna; Pienkowska-Grela, Barbara; Podgorska, Agnieszka; Zub, Renata; Olbryt, Magdalena; Pamula-Pilat, Jolanta; Lisowska, Katarzyna M; Grzybowska, Ewa; Rubel, Tymon; Dansonka-Mieszkowska, Agnieszka; Konopka, Bozena; Kulesza, Magdalena; Lukasik, Martyna; Kupryjanczyk, Jolanta

Cytogenomic features of Richter transformation

里氏转化的细胞基因组学特征

PROM1, CXCL8, RUNX1, NAV1 and TP73 genes as independent markers predictive of prognosis or response to treatment in two cohorts of high-grade serous ovarian cancer patients

PROM1、CXCL8、RUNX1、NAV1 和 TP73 基因作为独立标志物，可预测两组高级别浆液性卵巢癌患者的预后或治疗反应。

Cryptic MYC insertions in Burkitt lymphoma: New data and a review of the literature.

Burkitt淋巴瘤中的隐匿性MYC插入：新数据和文献综述

Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer

EMSY基因表达和多态性在卵巢癌中的临床意义

The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS

11q 获得/缺失异常在伴有 11q 异常的 MYC 阴性 Burkitt 样淋巴瘤、MYC 阳性 Burkitt 淋巴瘤以及 MYC 阳性高级别 B 细胞淋巴瘤（未另行分类）中反复出现。

A novel IGH@ gene rearrangement associated with CDKN2A/B deletion in young adult B-cell acute lymphoblastic leukemia.

在青年成人B细胞急性淋巴细胞白血病中发现一种与CDKN2A/B缺失相关的新型IGH@基因重排

Novel Cryptic Rearrangements in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Involving the MLL Gene.

涉及 MLL 基因的成人 B 细胞前体急性淋巴细胞白血病的新型隐匿性重排

The putative oncogene, CRNDE, is a negative prognostic factor in ovarian cancer patients

假定的癌基因CRNDE是卵巢癌患者的不良预后因素。